Publication & Citation Trends
Publications
0 total
Abstract PD5-02: 5-year outcomes and ctdna findings in the clever trial targeting disseminated dormant tumor cells
Cited by 0
Semantic Scholar
Abstract PS5-07-04: NRG-BR009: A phase III trial evaluating addition of adjuvant chemotherapy to Ovarian Function Suppression + Endocrine Therapy in premenopausal women with pN0-1, HR+/HER2- breast cancer and recurrence score ≤25 (OFSET)
Cited by 0
Semantic Scholar
Abstract PS2-02-26: Treatment patterns and prognosis of patients with HER2-negative early breast cancer and germline pathogenic variants in BRCA1, BRCA2, ATM, CHEK2 and PALB2
Cited by 0
Semantic Scholar
Abstract PS4-07-15: A single preoperative pembrolizumab dose plus a single subablative radiotherapy fraction (7 Gy) elicits anti-tumor immune response and increases stromal tumor infiltrating lymphocytes in triple negative breast cancer: a phase 1b/2 study
Cited by 0
Semantic Scholar
Abstract 2994: Integrative pathway analysis of I-SPY2 HER2+ breast cancers reveals drug-repurposing opportunities
Cited by 0
Semantic Scholar
Abstract RF5-06: Pathologic complete response rates (pCR) after the novel HER2 ADC ARX788: Results from the I-SPY2.2 trial
Cited by 0
Semantic Scholar
Abstract PS4-07-07: Factors associated with pCR and distant recurrence in patients with early-stage TNBC treated with KN522
Cited by 0
Semantic Scholar
Abstract PS1-01-05: Pneumonitis but not other immune related adverse events (irAEs) associate with pre-treatment immune signatures in early-stage breast cancer patients receiving neoadjuvant immunotherapy (IO): results from 5 IO arms in I-SPY2
Cited by 0
Semantic Scholar
Research Topics
Advanced Breast Cancer Therapies
(96)
HER2/EGFR in Cancer Research
(63)
Breast Cancer Treatment Studies
(53)
Cancer Treatment and Pharmacology
(47)
Cancer Immunotherapy and Biomarkers
(27)
Affiliations
Tufts Medical Center
Visiting Nurse Service of New York
National Institutes of Health
University of Minnesota
Minneapolis Institute of Arts